After adjustment for possible confounding factors, higher serum VAP-1 levels were associated with an increased risk of MACE in patients with AF (HR = 5.28, 95% CI = 0.64–43.66) and (HR = 28.35, 95% CI = 2.82–284.92). Here, AOC3 is linked to atrial fibrillation.